6 reports of this reaction
15.4% of all GELSEMIUM SEMPERVIRENS ROOT reports
#1 most reported adverse reaction
RASH is the #1 most commonly reported adverse reaction for GELSEMIUM SEMPERVIRENS ROOT, manufactured by Boiron. There are 6 FDA adverse event reports linking GELSEMIUM SEMPERVIRENS ROOT to RASH. This represents approximately 15.4% of all 39 adverse event reports for this drug.
Patients taking GELSEMIUM SEMPERVIRENS ROOT who experience rash should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
RASH is a frequently reported adverse event for GELSEMIUM SEMPERVIRENS ROOT, accounting for a significant proportion of all reports.
In addition to rash, the following adverse reactions have been reported for GELSEMIUM SEMPERVIRENS ROOT:
The following drugs have also been linked to rash in FDA adverse event reports:
RASH has been reported as an adverse event in 6 FDA reports for GELSEMIUM SEMPERVIRENS ROOT. This does not prove causation, but indicates an association observed in post-market surveillance data.
RASH accounts for approximately 15.4% of all adverse event reports for GELSEMIUM SEMPERVIRENS ROOT, making it one of the most commonly reported side effect.
If you experience rash while taking GELSEMIUM SEMPERVIRENS ROOT, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.